US Patent 10272143 Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
Patent 10272143 was granted and assigned to Immunovative Therapies on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10272143 Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
